At first glance, the luminous image rolling across a conference room wall at Affymetrix Inc. looks like mysterious transmissions from an alien race using an intricate language we don't understand. But ...

BioDiscovery, Inc. has announced that two of its products have achieved GeneChip-compatible™ status with the Affymetrix Inc. GeneChip microarray platform and that it has joined Affymetrix ...

The GeneChip® Scanner 3000 7G is an extension of the GeneChip® Scanner 3000 (GCS 3000) series that allows you to scan next-generation higher-density arrays, including SNP arrays with up to 900,000 ...

Stone Bond Technologies has announced that its Enterprise Enabler® and EE-LIMS systems have achieved GeneChip-compatible™ status with the Affymetrix Inc. GeneChip® microarray platform for gene ...

Affymetrix, Inc. (NASDAQ:AFFX) today launched the GeneChip(R) miRNA 2.0 Array. This enhanced version of its best-in-class microRNA (miRNA) interrogation solution will support the research community's ...

Affymetrix (NASDAQ: AFFX) introduces GeneChip® WT Pico Kit for gene expression array target preparation from as little as 100 pg of total RNA input. Working with as few as 10 cells, the new kit offers ...

UC Riverside researchers, in partnership with Affymetrix, Inc., have designed a chip that can improve citrus varieties and suggest ways to better manage them. By helping determine which genes are ...

Affymetrix microarray-based gene-expression technology was used. ChipDX reports the discovery and validation of a genetic signature for early-stage colon cancer. The firm is developing an online ...

Researchers at the Hong Kong University of Science and Technology have developed a genechip-based technology, a faster and cheaper means of testing the authenticity of traditional Chinese medicine.

The Massachusetts Institute of Technology (MIT) has filed a lawsuit against DNA microarray company Affymetrix, claiming that some of the company's GeneChip technology — widely used for high-throughput ...